Principal Securities’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.89M Buy
39,152
+2,612
+7% +$122K 0.03% 517
2025
Q4
$1.77M Buy
36,540
+1,073
+3% +$53.2K 0.03% 521
2025
Q3
$1.67M Sell
35,467
-3,529
-9% -$170K 0.03% 502
2025
Q2
$1.88M Buy
38,996
+2,866
+8% +$146K 0.04% 433
2025
Q1
$1.74M Hold
36,130
0.04% 401
2024
Q4
$1.74M Sell
36,130
-8,920
-20% -$454K 0.04% 400
2024
Q3
$2.6M Buy
45,050
+2,555
+6% +$138K 0.06% 271
2024
Q2
$2.06M Buy
42,495
+3,440
+9% +$166K 0.06% 293
2024
Q1
$1.9M Buy
39,055
+3,692
+10% +$180K 0.06% 284
2023
Q4
$1.76M Buy
+35,363
New +$1.73M 0.07% 275

Other funds holding SNY

Principal Securities's SNY Position: Q1 2026 in Review

Principal Securities increased its Sanofi (SNY) stake by 7.1% in Q1 2026, buying an estimated $122K and bringing the position to 39,152 shares worth $1.89M. The position accounts for 0.03% of the portfolio, ranked #517.

Principal Securities first reported a position in SNY in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.6M in Q3 2024. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Principal Securities held 39,152 shares of Sanofi worth $1.89M as of Q1 2026.
  • Principal Securities bought 2,612 Sanofi shares in Q1 2026, an estimated $122K.
  • Sanofi made up 0.03% of Principal Securities's portfolio in Q1 2026, its #517 holding.
  • Principal Securities first reported a position in Sanofi in Q4 2023 and has held it in 10 quarters since.
  • Principal Securities's Sanofi position peaked at $2.6M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.